Probe-capture targeted next-generation sequencing: A novel approach for pathogen and antimicrobial resistance detection in sepsis

References

[1] Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016; 315: 801-810.

[2] Jacobi J. Pathophysiology of sepsis. Am J Health Syst Pharm. 2002; 59(Suppl 1): S3-S8.

[3] Thompson K, Venkatesh B, Finfer S. Sepsis and septic shock: current approaches to management. Intern Med J. 2019; 49: 160-170.

[4] Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet. 2020; 395: 200-211.

[5] Bates D, Sands K, Miller E, et al. Predicting bacteremia in patients with sepsis syndrome. Academic Medical Center Consortium Sepsis Project Working Group. J Infect Dis. 1997; 176: 1538-1551.

[6] Healthcare, A.C.o.S.a.Q.i. Bloodstream Infection (BSI) Definition. 2024.

[7] Paul M, Shani V, Muchtar E, Kariv G, Robenshtok E, Leibovici L. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother. 2010; 54: 4851-4863.

[8] Ferrer R, Martin-Loeches I, Phillips G, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014; 42: 1749-1755.

[9] Novosad SA, Sapiano MR, Grigg C, et al. Vital Signs: epidemiology of Sepsis: prevalence of Health Care Factors and Opportunities for Prevention. MMWR Morb Mortal Wkly Rep. 2016; 65: 864-869.

[10] Beekmann S, Diekema D, Chapin K, Doern G. Effects of rapid detection of bloodstream infections on length of hospitalization and hospital charges. J Clin Microbiol. 2003; 41: 3119-3125.

[11] Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006; 34: 1589-1596.

[12] Peters R, van Agtmael M, Danner S, Savelkoul P, Vandenbroucke-Grauls C. New developments in the diagnosis of bloodstream infections. Lancet Infect Dis. 2004; 4: 751-760.

[13] Tsalik EL, Jones D, Nicholson B, et al. Multiplex PCR to diagnose bloodstream infections in patients admitted from the emergency department with sepsis. J Clin Microbiol. 2010; 48: 26-33.

[14] DeSimone DC, Garrigos ZE, Marx GE, et al. Blood culture-negative endocarditis: a scientific statement from the American Heart Association: endorsed by the International Society for Cardiovascular Infectious Diseases. J Am Heart Assoc. 2025; 14:e040218.

[15] Zhao Y, Zhang W, Zhang X. Application of metagenomic next-generation sequencing in the diagnosis of infectious diseases. Front Cell Infect Microbiol. 2024; 14:1458316.

[16] Simner P, Miller S, Carroll K. Understanding the promises and hurdles of metagenomic next-generation sequencing as a diagnostic tool for infectious diseases. Clin Infect Dis. 2018; 66: 778-788.

[17] Chiu C, Miller S. Clinical metagenomics. Nat Rev Genet. 2019; 20: 341-355.

[18] Gu W, Miller S, Chiu C. Clinical metagenomic next-generation sequencing for pathogen detection. Annu Rev Pathol. 2019; 14: 319-338.

[19] Jing C, Chen H, Liang Y, et al. Clinical evaluation of an improved metagenomic next-generation sequencing test for the diagnosis of bloodstream infections. Clin Chem. 2021; 67: 1133-1143.

[20] Yan G, Liu J, Chen W, et al. Metagenomic next-generation sequencing of bloodstream microbial cell-free nucleic acid in children with suspected sepsis in pediatric intensive care unit. Front Cell Infect Microbiol. 2021; 11:665226.

[21] Miller S, Naccache SN, Samayoa E, et al. Laboratory validation of a clinical metagenomic sequencing assay for pathogen detection in cerebrospinal fluid. Genome Res. 2019; 29: 831-842.

[22] Thoendel MJ, Jeraldo PR, Greenwood-Quaintance KE, et al. Identification of Prosthetic Joint Infection Pathogens Using a Shotgun Metagenomics Approach. Clin Infect Dis. 2018; 67: 1333-1338.

[23] Charalampous T, Kay GL, Richardson H, et al. Nanopore metagenomics enables rapid clinical diagnosis of bacterial lower respiratory infection. Nat Biotechnol. 2019; 37: 783-792.

[24] Opota O, Jaton K, Greub G. Microbial diagnosis of bloodstream infection: towards molecular diagnosis directly from blood. Clin Microbiol Infect. 2015; 21: 323-331.

[25] Kreger B, Craven D, Carling P, McCabe W. Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. Am J Med. 1980; 68: 332-343.

[26] Wain J, Diep TS, Ho VA, et al. Quantitation of bacteria in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility, and antibiotic resistance. J Clin Microbiol. 1998; 36: 1683-1687.

[27] Henry S, DeMaria , McCabe W. Bacteremia due to Fusobacterium species. Am J Med. 1983; 75: 225-231.

[28] Nielsen ME, Søgaard KK, Karst SM, Krarup AL, Albertsen M, Nielsen HL. Application of rapid Nanopore metagenomic cell-free DNA sequencing to diagnose bloodstream infections: a prospective observational study. Microbiol Spectr. 2025; 13:e0329524.

[29] Rydzak T, Groves RA, Zhang R, et al. Metabolic preference assay for rapid diagnosis of bloodstream infections. Nat Commun. 2022; 13: 2332.

[30] Di Pilato V, Bonaiuto C, Morecchiato F, Antonelli A, Giani T, Rossolini G. Next-generation diagnostics of bloodstream infections enabled by rapid whole-genome sequencing of bacterial cells purified from blood cultures. EBioMedicine. 2025; 114:105633.

[31] Avershina E, Khezri A, Ahmad R. Clinical diagnostics of bacterial infections and their resistance to antibiotics-current state and whole genome sequencing implementation perspectives. Antibiotics. 2023; 12(4): 781.

[32] Yi X, Lu H, Liu X, et al. Unravelling the enigma of the human microbiome: evolution and selection of sequencing technologies. Microb Biotechnol. 2024; 17:e14364.

[33] Cai S, Yuan J, Li Y, et al. Etiological diagnostic performance of probe capture-based targeted next-generation sequencing in bloodstream infection. J Thorac Dis. 2024; 16: 2539-2549.

[34] Gaudin M, Desnues C. Hybrid capture-based next generation sequencing and its application to human infectious diseases. Front Microbiol. 2018; 9: 2924.

[35] Meng Z, Wang S, Yu L, et al. A novel fast hybrid capture sequencing method for high-efficiency common human coronavirus whole-genome acquisition. mSystems. 2024; 9:e0122223.

[36] Pham J, Su L, Hanson K, Hogan C. Sequence-based diagnostics and precision medicine in bacterial and viral infections: from bench to bedside. Curr Opin Infect Dis. 2023; 36: 228-234.

[37] Lesnik E, Freier S. Relative thermodynamic stability of DNA, RNA, and DNA:RNA hybrid duplexes: relationship with base composition and structure. Biochemistry. 1995; 34: 10807-10815.

[38] Hodges E, Xuan Z, Balija V, et al. Genome-wide in situ exon capture for selective resequencing. Nat Genet. 2007; 39: 1522-1527.

[39] Chen R, Im H, Snyder M. Whole-exome enrichment with the Agilent SureSelect Human All Exon Platform. Cold Spring Harb Protoc. 2015; 2015: 626-633.

[40] Chen R, Im H, Snyder M. Whole-exome enrichment with the Illumina TruSeq Exome Enrichment Platform. Cold Spring Harb Protoc. 2015; 2015: 642-648.

[41] Calvo SE, Compton AG, Hershman SG, et al. Molecular diagnosis of infantile mitochondrial disease with targeted next-generation sequencing. Sci Transl Med. 2012; 4:118ra110.

[42] Gai X, Ghezzi D, Johnson M, et al. Mutations in FBXL4, encoding a mitochondrial protein, cause early-onset mitochondrial encephalomyopathy. Am J Hum Genet. 2013; 93: 482-495.

[43] Sikkema-Raddatz B, Johansson LF, de Boer EN, et al. Targeted next-generation sequencing can replace Sanger sequencing in clinical diagnostics. Hum Mutat. 2013; 34: 1035-1042.

[44] Schrock AB, Pavlick D, Klempner SJ, et al. Hybrid capture-based genomic profiling of circulating tumor DNA from patients with advanced cancers of the gastrointestinal tract or anus. Clin Cancer Res. 2018; 24: 1881-1890.

[45] Hernández-Neuta I, Magoulopoulou A, Pineiro F, Lisby JG, Gulberg M, Nilsson M. Highly multiplexed targeted sequencing strategy for infectious disease surveillance. BMC Biotechnol. 2023; 23: 31.

[46] Kantor R, Jiang M. Considerations and opportunities for probe capture enrichment sequencing of emerging viruses from wastewater. Environ Sci Technol. 2024; 58: 8161-8168.

[47] Iwase SC, Miyazato P, Katsuya H, et al. HIV-1 DNA-capture-seq is a useful tool for the comprehensive characterization of HIV-1 provirus. Sci Rep. 2019; 9:12326.

[48] Thomson E, Ip CLC, Badhan A, et al. Comparison of next-generation sequencing technologies for comprehensive assessment of full-length hepatitis C viral genomes. J Clin Microbiol. 2016; 54: 2470-2484.

[49] Charre C, Ginevra C, Sabatier M, et al. Evaluation of NGS-based approaches for SARS-CoV-2 whole genome characterisation. Virus Evol. 2020; 6:veaa075.

[50] Brown AC, Bryant JM, Einer-Jensen K, et al. Rapid whole-genome sequencing of Mycobacterium tuberculosis isolates directly from clinical samples. J Clin Microbiol. 2015; 53: 2230-2237.

[51] Amorim-Vaz S, Tran Vdu T, Pradervand S, Pagni M, Coste A, Sanglard D. RNA enrichment method for quantitative transcriptional analysis of pathogens in vivo applied to the fungus Candida albicans. mBio. 2015; 6: e00942-00915.

[52] Mendoza RP, Doytcheva K, Ud Dean M, et al. Whole exome sequencing of placental chorangioma. Placenta. 2024; 149: 13-17.

[53] Bakhit Y, Tesson C, Ibrahim MO, et al. PLA2G6-associated late-onset Parkinsonism in a Sudanese family. Ann Clin Transl Neurol. 2023; 10: 983-989.

[54] Mourik K, Sidorov I, Carbo EC, et al. Comparison of the performance of two targeted metagenomic virus capture probe-based methods using reference control materials and clinical samples. J Clin Microbiol. 2024; 62:e0034524.

[55] Cancela F, Lizasoain A, Panzera Y, et al. Targeted enrichment sequencing utilizing a respiratory pathogen panel for genomic wastewater-based viral epidemiology in Uruguay. Food Environ Virol. 2025; 17: 14.

[56] Illumina. Analytical performance of the Respiratory Pathogen ID/AMR Panel. 2023.

[57] Smith SD, Choi J, Ricker N, et al. Diversity of antibiotic resistance genes and transfer elements-quantitative monitoring (DARTE-QM): a method for detection of antimicrobial resistance in environmental samples. Commun Biol. 2022; 5: 216.

[58] Weeber P, Singh N, Lapierre P, et al. A novel hybridization capture method for direct whole genome sequencing of clinical specimens to inform Legionnaires' disease investigations. J Clin Microbiol. 2024; 62:e0130523.

[59] Sun Q, Teng R, Shi Q, et al. Clinical implement of Probe-Capture Metagenomics in sepsis patients: a multicentre and prospective study. Clin Transl Med. 2025; 15:e70297.

[60] Liu X, Gan Z, Lin Z, et al. Exploring the value of hybrid capture-based next-generation sequencing technology in the suspected diagnosis of bloodstream infections. PeerJ. 2024; 12:e18471.

[61] Han D, Li Z, Li R, Tan P, Zhang R, Li J. mNGS in clinical microbiology laboratories: on the road to maturity. Crit Rev Microbiol. 2019; 45: 668-685.

[62] Grundy BS, Parikh H, Jacob S, et al. Pathogen Detection Using Metagenomic Next-Generation Sequencing of Plasma Samples from Patients with Sepsis in Uganda. Microbiol Spectr. 2023; 11:e0431222.

[63] Caméléna F, Péan de Ponfilly G, Pailhoriès H, et al. Multicenter evaluation of the filmarray blood culture identification 2 panel for pathogen detection in bloodstream infections. Microbiol Spectr. 2023; 11:e0254722.

[64] Kuchinski KS, Loos KD, Suchan DM, et al. Targeted genomic sequencing with probe capture for discovery and surveillance of coronaviruses in bats. Elife. 2022; 11:e79777.

[65] Buddle S, Forrest L, Akinsuyi N, et al. Evaluating metagenomics and targeted approaches for diagnosis and surveillance of viruses. Genome Med. 2024; 16: 111.

[66] Wylie T, Wylie K, Herter B, Storch G. Enhanced virome sequencing using targeted sequence capture. Genome Res. 2015; 25: 1910-1920.

[67] Briese T, Kapoor A, Mishra N, et al. Virome capture sequencing enables sensitive viral diagnosis and comprehensive virome analysis. mBio. 2015; 6: e01491-01415.

[68] Kuchinski K, Duan J, Himsworth C, Hsiao W, Prystajecky N. ProbeTools: designing hybridization probes for targeted genomic sequencing of diverse and hypervariable viral taxa. BMC Genomics. 2022; 23: 579.

[69] Cheng X, Goktas MT, Williamson LM, et al. Enhancing clinical genomic accuracy with panelGC: a novel metric and tool for quantifying and monitoring GC biases in hybridization capture panel sequencing. Brief Bioinform. 2024; 25(5):bbae442.

[70] Dickson ZW, Hackenberger D, Kuch M, et al. Probe design for simultaneous, targeted capture of diverse metagenomic targets. Cell Rep Methods. 2021; 1:100069.

[71] Zhuo Z, Rong W, Li H, et al. Long-read sequencing reveals the structural complexity of genomic integration of HBV DNA in hepatocellular carcinoma. NPJ Genom Med. 2021; 6: 84.

[72] Sundararaman B, Vershinina AO, Hershauer S, et al. A method to generate capture baits for targeted sequencing. Nucleic Acids Res. 2023; 51:e69.

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Discovery published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.